A Study to Evaluate the Efficacy and Safety of Rivaroxaban Venous Thromboembolism (VTE) Prophylaxis in Ambulatory Cancer Participants
Condition(s):NeoplasmsLast Updated:September 12, 2019Completed
Hide Studies Not Open or Pending
Condition(s):NeoplasmsLast Updated:September 12, 2019Completed
Condition(s):Ischemic Stroke; Intracranial Atherosclerosis; StenosisLast Updated:December 21, 2023Not yet recruiting
Condition(s):Thromboses, Deep Vein; Surgery–ComplicationsLast Updated:October 17, 2017Unknown status
Condition(s):Venous Thrombosis; Pulmonary Embolism; Atrial Fibrillation; Acute Coronary SyndromeLast Updated:September 27, 2021Completed
Condition(s):Trauma; Hypothermia; Acidosis; BleedingLast Updated:March 1, 2023Completed
Condition(s):Embolism, Atrial Fibrillation and Venous ThrombosisLast Updated:September 1, 2015Completed
Condition(s):Ventricular Mural ThrombosisLast Updated:June 29, 2022Recruiting
Condition(s):Peripheral Artery DiseaseLast Updated:December 8, 2020Completed
Condition(s):Cerebral Vein ThrombosisLast Updated:February 16, 2023Completed
Condition(s):Prophylaxis of Venous ThromboembolismLast Updated:April 11, 2017Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.